HomeNRIX • NASDAQ
add
Nurix Therapeutics Inc
Previous close
$19.65
Day range
$19.24 - $20.41
Year range
$7.79 - $29.56
Market cap
1.52B USD
Avg Volume
750.12K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Nov 2024info | Y/Y change |
|---|---|---|
Revenue | 13.28M | -12.37% |
Operating expense | 232.35M | 2,055.37% |
Net income | -58.55M | -39.55% |
Net profit margin | -440.75 | -59.25% |
Earnings per share | -0.75 | 2.60% |
EBITDA | -62.11M | -38.63% |
Effective tax rate | -0.01% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Nov 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 609.58M | 111.73% |
Total assets | 669.34M | 88.23% |
Total liabilities | 142.35M | -8.22% |
Total equity | 526.99M | — |
Shares outstanding | 75.87M | — |
Price to book | 2.83 | — |
Return on assets | -27.33% | — |
Return on capital | -33.70% | — |
Cash Flow
Net change in cash
| (USD) | Nov 2024info | Y/Y change |
|---|---|---|
Net income | -58.55M | -39.55% |
Cash from operations | -48.75M | -282.66% |
Cash from investing | -140.82M | -879.73% |
Cash from financing | 200.52M | 2,864,485.71% |
Net change in cash | 10.95M | -11.12% |
Free cash flow | -65.86M | -1,254.53% |
About
Founded
2009
Headquarters
Website
Employees
284
